# Sigilon Therapeutics, Inc.

Sigilon Therapeutics, Inc. is a company headquartered in Cambridge, MA, United States.

## Company overview

- **Legal name:** Sigilon Therapeutics, Inc.
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Cambridge, MA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001821323

## About

Sigilon Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001821323, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2023-03-14, it reported annual revenue of USD 12,944,000; net income of USD -43,561,000; total assets of USD 87,278,000 for the fiscal period ended 2022-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2022 (period ended 2022-12-31)

- **Revenue:** $12.9M (USD 12,944,000)
- **Net income:** -$43.6M (USD -43,561,000)
- **Total assets:** $87.3M (USD 87,278,000)
- **Cash and equivalents:** $42.1M (USD 42,066,000)
- **Operating cash flow:** -$51.5M (USD -51,474,000)
- **Later filings:** Net income: shown as originally filed; later filings report different values for the same periods.

### FY2021 (period ended 2021-12-31)

- **Revenue:** $9.6M (USD 9,599,000)
- **Net income:** -$77.3M (USD -77,311,000)
- **Total assets:** $144.4M (USD 144,369,000)
- **Cash and equivalents:** $107.1M (USD 107,143,000)
- **Operating cash flow:** -$78.4M (USD -78,405,000)
- **Later filings:** Net income: shown as originally filed; later filings report different values for the same periods.

## Recent SEC filings

- Form 8-K — filed 2023-08-11 — period 2023-08-11 — 8-K
- Form 10-Q — filed 2023-08-07 — period 2023-06-30 — 10-Q
- Form SC 13D — filed 2023-07-07 — SC 13D
- Form 8-K — filed 2023-06-29 — period 2023-06-28 — FORM 8-K
- Form 8-K — filed 2023-05-22 — period 2023-05-19 — 8-K
- Form 10-Q — filed 2023-05-09 — period 2023-03-31 — 10-Q
- Form 8-K — filed 2023-05-09 — period 2023-05-09 — 8-K
- Form DEF 14A — filed 2023-04-06 — period 2023-05-19 — DEF 14A
- Form 10-K — filed 2023-03-14 — period 2022-12-31 — 10-K
- Form 8-K — filed 2023-03-14 — period 2023-03-14 — 8-K
- Form 8-K — filed 2023-03-10 — period 2023-03-10 — 8-K
- Form 8-K — filed 2023-02-28 — period 2023-02-23 — 8-K

---

Updated: 2026-10-23T20:08:00Z

Canonical page: https://altss.com/profile/sigilon-therapeutics-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology